Pharmaceutical

EMA CHMP endorses Mirum Pharmaceuticals’ LIVMARLI for PFIC

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended Mirum Pharmaceuticals’ LIVMARLI.

Jun 4, 2024 - 04:00
EMA CHMP endorses Mirum Pharmaceuticals’ LIVMARLI for PFIC
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended Mirum Pharmaceuticals’ LIVMARLI.
Read the original article

Tags:

Previous Article

CHMP approves backing for first acanthamoeba keratitis treatment

Next Article

Inline, real-time PAT tool is a game-changer for pharma granulation sector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Eli Lilly doubles down on Oblique partnership for antibody generation

Eli Lilly doubles down on Oblique partnership for antib...

Aug 25, 2024

STAT+: Democrats urge government to rein in Medicare Advantage overpayments and denials

STAT+: Democrats urge government to rein in Medicare Ad...

Jan 26, 2024

Touchlight boosts DNA manufacturing capacity with latest expansion

Touchlight boosts DNA manufacturing capacity with lates...

May 26, 2023